Thailand plans to buy more generic AIDS drugs from India to cut the cost of treating its poorest patients after failing to win large enough discounts from drug makers including Merck & Co. and Abbott Laboratories…Public health minister, Mongkol Na Songkhla, said…“If their prices aren’t more than 5% above the generic drugs, we won’t hesitate to buy from them. Now, their prices are 20% higher.”…Thailand’s Food and Drug Administration director-general Siriwat Thiptharadol, is meeting “about twice a week” with pharmaceutical companies to continue price negotiations…[also refers to Matrix Laboratories, Sanofi-Aventis]